Heart Failure in Diabetes mellitus: Clinical Features and Prognostic Implications
- 1 April 2005
- journal article
- Published by S. Karger AG in JMIR AI
- Vol. 103 (3), 161-166
- https://doi.org/10.1159/000084587
Abstract
We defined the prevalence and impact on survival of clinical bedside variables in 385 patients with symptomatic congestive heart failure (CHF), of whom there were 176 with and 209 without diabetes mellitus. Patients were consecutively hospitalized and admitted for various acute conditions. Following discharge all-cause mortality was recorded. Prevalence and association of various variables with mortality were statistically analyzed. Prevailing in the diabetics versus nondiabetics were younger age (p < 0.05), pulmonary edema on admission (p = 0.002), using furosemide >80 mg/day (p < 0.01) for >1 year (p < 0.01) and hyponatremia (p = 0.01). Less prevalent were chronic lung disease (p < 0.01) and cardiac arrhythmias (p = 0.001). On follow-up extending up to 60 months, diabetic patients, especially those with fasting blood glucose levels on admission ≧180 mg/dl, survived for a shorter period of time than nondiabetics (p = 0.02). Associated with increased mortality in the diabetic group were female gender (p = 0.04), furosemide ≧80 mg/day (p < 0.001) and renal dysfunction (RD; p = 0.04). The respective variables in the nondiabetics were advanced age (p < 0.001) and RD (p = 0.002). Although they were younger, diabetic patients presented more severe CHF. It is recommended that special attention should be given to diabetic females, those using higher furosemide dosages and those suffering from RD.Keywords
This publication has 29 references indexed in Scilit:
- Adaptation and Maladaptation of the Heart in Diabetes: Part ICirculation, 2002
- Heart failure with preserved systolic functionJournal of the American College of Cardiology, 2001
- The prognosis of heart failure in the general population. The Rotterdam StudyEuropean Heart Journal, 2001
- Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trialEuropean Heart Journal, 2000
- Diabetes mellitus and congestive heart failureEuropean Heart Journal, 1999
- Mortality in a large population-based cohort of patients with drug-treated diabetes mellitus.American Journal of Public Health, 1998
- Diabetes mellitus, a predictor of morbidity and mortality in the studies of left ventricular dysfunction (SOLVD) trials and registryThe American Journal of Cardiology, 1996
- Heart Failure in WomenJMIR AI, 1995
- Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: Hyponatremia, hypokalemia, and hypomagnesemiaAmerican Heart Journal, 1994
- Acute myocardial infarction in diabetes mellitus and significance of congestive heart failure as a prognostic factorThe American Journal of Cardiology, 1988